Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial

Publisher： Karger

E-ISSN： 1421-9832|227|4|353-360

ISSN： 1018-8665

Source： Dermatology, Vol.227, Iss.4, 2013-11, pp. : 353-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

By  

Dermatology, Vol. 222, Iss. 1, 2010-12 ,pp. : 36-48

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin C Iontophoresis in Melasma

By  

Dermatology, Vol. 206, Iss. 4, 2003-06 ,pp. : 316-320

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Pimecrolimus Cream 1% in Mild-to-Moderate Chronic Hand Dermatitis: A Randomized, Double-Blind Trial

By  

Dermatology, Vol. 221, Iss. 1, 2010-06 ,pp. : 71-77

Karger

Access to resources Recommend Favorite

Ethyl Chloride as an Antipruritic Agent: A Double-Blind Placebo-Controlled Prospective Study

By  

Dermatology, Vol. 221, Iss. 4, 2010-11 ,pp. : 373-377

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Short-Term Itraconazole in Tinea pedis: A Double-Blind, Randomized, Placebo-Controlled Trial

By  

Dermatology, Vol. 197, Iss. 4, 1998-12 ,pp. : 368-372

Karger

Access to resources Recommend Favorite